Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia. LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors. A missense mutation in the L-type calcium channel Ca(V)1.2 leads to LQTS in patients with Timothy syndrome. To explore the effect of the Timothy syndrome mutation on the electrical activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes. Electrophysiological recording and calcium (Ca(2+)) imaging studies of these cells revealed irregular contraction, excess Ca(2+) influx, prolonged action potentials, irregular electrical activity and abnormal calcium transients in ventricular-like cells. We found that roscovitine, a compound that increases the voltage-dependent inactivation of Ca(V)1.2 (refs 6-8), restored the electrical and Ca(2+) signalling properties of cardiomyocytes from Timothy syndrome patients. This study provides new opportunities for studying the molecular and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Earlier studies in cardiomyocytes12 from TS individuals indicated that roscovitine2,3,29, a cyclin-dependent kinase blocker that also increases L-type channel inactivation, can reduce the prolongation of the cardiac AP in cells from TS individuals.”
From Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome (2011) · cites this paper as [12]
In the citing paper
“Some of the hiPS cell lines used in this study were extensively characterized previously23,61 using immunostaining with anti–NANOG and TRA 2–49/6E antibodies, karyotyping, generation of teratoma in nude mice and mapping of viral integration sites (Extended Data Fig. 1a).”
From Neuronal defects in a human cellular model of 22q11.2 deletion syndrome (2020) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310 · cited 1×
“We next reprogrammed the fibroblasts to generate iPSCs using four retroviruses containing SOX2, OCT3/4, KLF4 and C-MYC 20 , 21 .”
CaV1.2 Calcium Channel Dysfunction Causes a Multisystem Disorder Including Arrhythmia and Autism
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., Napolitano, C., Schwartz, P. J., Joseph, R. M., Condouris, K., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.011 · Cited by 1,586
Sudden Death Due to Cardiac Arrhythmias
Huikuri, H. V., Castellanos, A., & Myerburg, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmra000650 · Cited by 1,466
Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., & Kamp, T. J. (2009) · Circulation Research · doi:10.1161/circresaha.108.192237 · Cited by 1,407
Meijer, L., Borgne, A., Mulner, O., Chong, J. P. J., Blow, J. J., Inagaki, N., Inagaki, M., Delcros, J., & Moulinoux, J. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.t01-2-00527.x · Cited by 1,352
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Generation of Pluripotent Stem Cells from Adult Mouse Liver and Stomach Cells
Aoi, T., Yae, K., Nakagawa, M., Ichisaka, T., Okita, K., Takahashi, K., Chiba, T., & Yamanaka, S. (2008) · Science · doi:10.1126/science.1154884 · Cited by 1,058
He, J.-Q., Ma, Y., Lee, Y., Thomson, J. A., & Kamp, T. J. (2003) · Circulation Research · doi:10.1161/01.res.0000080317.92718.99 · Cited by 800
Schwartz, P. J. (1997) · Current Problems in Cardiology · doi:10.1016/s0146-2806(97)80009-6 · Cited by 693
Cited by
Items 301–400 of 720
Mechanisms underlying epilepsies associated with sodium channel mutations
Steinlein, O. K. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63326-2.00005-3 · Cited by 28
Human Stem Cell-Derived Cardiac Model of Chronic Drug Exposure
Nunes, S. S., Feric, N. T., Pahnke, A., Miklas, J. W., Li, M., Coles, J. G., Gagliardi, M., Keller, G. M., & Radisic, M. (2016) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00496 · Cited by 28
Lodrini, A. M., Barile, L., Rocchetti, M., & Altomare, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020507 · Cited by 28
L-Type Ca2+ Channel Function During Timothy Syndrome
Dixon, R. E., Cheng, E. P., Mercado, J., & Santana, L. F. (2012) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2012.06.015 · Cited by 28
Toward a hierarchy of mechanisms in CaMKII-mediated arrhythmia
Vincent, K. P., McCulloch, A. D., & Edwards, A. G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00110 · Cited by 28
Human induced pluripotent stem cell for modeling cardiovascular diseases
Liang, P., & Du, J. (2014) · Regenerative Medicine Research · doi:10.1186/2050-490x-2-4 · Cited by 28
hiPSC Modeling of Inherited Cardiomyopathies
Jung, G., & Bernstein, D. (2014) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-014-0320-7 · Cited by 28
Modeling Long-QT Syndromes with iPS Cells
Sinnecker, D., Goedel, A., Dorn, T., Dirschinger, R. J., Moretti, A., & Laugwitz, K. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9416-1 · Cited by 27
Reilly, L., Munawar, S., Zhang, J., Crone, W. C., & Eckhardt, L. L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.966094 · Cited by 27
Napolitano, C., Bloise, R., & Priori, S. G. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00095-9 · Cited by 27
Li, W., Zheng, N.-Z., Yuan, Q., Xu, K., Yang, F., Gu, L., Zheng, G.-Y., Luo, G., Fan, C., Ji, G., et al. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-016-1444-x · Cited by 27
Lee, S., Lee, H.-A., Choi, S. W., Kim, S. J., & Kim, K. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.01.015 · Cited by 27
Will iPSC-cardiomyocytes revolutionize the discovery of drugs for heart disease?
Bruyneel, A. A. N., McKeithan, W. L., Feyen, D. A. M., & Mercola, M. A. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.07.003 · Cited by 27
The Application of Induced Pluripotent Stem Cells in Cardiac Disease Modeling and Drug Testing
Ye, L., Ni, X., Zhao, Z., Lei, W., & Hu, S. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9811-3 · Cited by 27
Juhola, M., Penttinen, K., Joutsijoki, H., Varpa, K., Saarikoski, J., Rasku, J., Siirtola, H., Iltanen, K., Laurikkala, J. P. S., Hyyrö, H., et al. (2015) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2015.03.016 · Cited by 27
Limberg, M. M., Zumhagen, S., Netter, M. F., Coffey, A. J., Grace, A. A., Rogers, J., Boeckelmann, D., Rinné, S., Stallmeyer, B., Decher, N., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0353-1 · Cited by 27
Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Bezzerides, V. J., Zhang, D., & Pu, W. T. (2016) · Circulation Journal · doi:10.1253/circj.cj-16-1113 · Cited by 26
In Vitro Uses of Human Pluripotent Stem Cell-Derived Cardiomyocytes
Matsa, E., & Denning, C. N. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9376-5 · Cited by 26
Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
Seah, S., Farran, C. A. E., Warrier, T., Xu, J., & Loh, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226119 · Cited by 26
Dowaidar, M. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/3nwzd · Cited by 26
Arrhythmia Mechanisms in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
Paci, M., Penttinen, K., Pekkanen-Mattila, M., & Koivumäki, J. T. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000972 · Cited by 26
Cardiovascular science: opportunities for translating research into improved care
Braunwald, E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67541 · Cited by 26
New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models
Sharma, A. K., Singh, S., Bhat, M., Gill, K., Zaid, M., Kumar, S., Shakya, A., Tantray, J., Jose, D., Gupta, R., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-41942-4 · Cited by 26
Bai, J., Wang, K., Li, Q., Yuan, Y., & Zhang, H. (2016) · Scientific Reports · doi:10.1038/srep31262 · Cited by 26
Christidi, E., Huang, H., & Brunham, L. R. (2018) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2018.06.002 · Cited by 26
Roxland, B. E. (2012) · Regenerative Medicine · doi:10.2217/rme.12.20 · Cited by 26
Mack, D. L., Guan, X., Wagoner, A. L., Walker, S. J., & Childers, M. K. (2014) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000000141 · Cited by 25
Modeling heart disease in a dish: From somatic cells to disease-relevant cardiomyocytes
Zanella, F., Lyon, R. C., & Sheikh, F. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.06.002 · Cited by 25
Paulsen, B. D. S., Silveira, M. S., Galina, A., & Rehen, S. K. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.10.009 · Cited by 25
Harnessing the Potential of Stem Cells for Disease Modeling: Progress and Promises
Argentati, C., Tortorella, I., Bazzucchi, M., Morena, F., & Martino, S. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10010008 · Cited by 25
Bekhite, M. M., & Schulze, P. C. (2021) · Cells · doi:10.3390/cells10123483 · Cited by 25
Seki, T., Yuasa, S., Kusumoto, D., Kunitomi, A., Saito, Y., Tohyama, S., Yae, K., Kishino, Y., Okada, M., Hashimoto, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085645 · Cited by 24
Direct Reprogramming into Desired Cell Types by Defined Factors
Ieda, M. (2013) · The Keio Journal of Medicine · doi:10.2302/kjm.2012-0017-re · Cited by 24
Young, W. (2012) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.s10-010 · Cited by 24
The Future of Induced Pluripotent Stem Cells for Cardiac Therapy and Drug Development
Thorrez, L., & Sampaolesi, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797904154 · Cited by 24
Jeziorowska, D., Korniat, A., Salem, J., Fish, K. M., & Hulot, J. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1064109 · Cited by 24
Precision medicine for long QT syndrome: patient-specific iPSCs take the lead
Yu, Y., Deschênes, I., & Zhao, M. (2023) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2022.43 · Cited by 24
Early Repolarization Syndrome; Mechanistic Theories and Clinical Correlates
Mercer, B. N., Begg, G. A., Page, S. P., Bennett, C., Tayebjee, M. H., & Mahida, S. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00266 · Cited by 24
Schwan, J., & Campbell, S. G. (2015) · Biomarker Insights · doi:10.4137/bmi.s23912 · Cited by 23
Calcineurin Controls Voltage-Dependent-Inactivation (VDI) of the Normal and Timothy Cardiac Channels
Cohen-Kutner, M., Yahalom, Y., Trus, M., & Atlas, D. (2012) · Scientific Reports · doi:10.1038/srep00366 · Cited by 23
Kidney bioengineering in regenerative medicine: An emerging therapy for kidney disease
Lin, Y.-Q., Wang, L., Pan, L., Wang, H., Zhu, G., Liu, W., Wang, J., Braddock, M., & Zheng, M. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.10.004 · Cited by 23
Concise Review: The Magic Act of Generating Induced Pluripotent Stem Cells: Many Rabbits in the Hat
Mostoslavsky, G. (2011) · Stem Cells · doi:10.1002/stem.742 · Cited by 23
Perspectives of induced pluripotent stem cells for cardiovascular system regeneration
Csöbönyeiová, M., Polák, Š., & Danišovič, Ľ. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370214565976 · Cited by 22
Preininger, M. K., Singh, M., & Xu, C. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-45457-3_10 · Cited by 22
Shox2: The Role in Differentiation and Development of Cardiac Conduction System
Hu, W., Xin, Y., Zhao, Y., & Hu, J. J. (2018) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.244.177 · Cited by 22
A mystery unraveled: nontumorigenic pluripotent stem cells in human adult tissues
Simerman, A. A., Perone, M. J., Gimeno, M. L., Dumesic, D. A., & Chazenbalk, G. D. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.900538 · Cited by 22
Kamdar, F. D., Kamdar, A. K., Koyano‐Nakagawa, N., Garry, M. G., & Garry, D. J. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.04.010 · Cited by 22
Current status of induced pluripotent stem cells in cardiac tissue regeneration and engineering
Liu, Z., Zhou, J., Wang, H., Zhao, M., & Wang, C. (2013) · Regenerative Medicine Research · doi:10.1186/2050-490x-1-6 · Cited by 22
Garcia, M. I., Dame, K., Charwat, V., Siemons, B. A., Finsberg, H. N. T., Bhardwaj, B., Yokosawa, R., Goswami, I., Bruckner, D., Wall, S., et al. (2025) · Nature Protocols · doi:10.1038/s41596-025-01166-4 · Cited by 21
Induced Pluripotent Stem Cells and Their Use in Cardiac and Neural Regenerative Medicine
Skalová, Š., Švadláková, T., Qureshi, W. M. S., Dev, K., & Mokrý, J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16024043 · Cited by 21
White, M. C., Pang, L., & Yang, X. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.05.025 · Cited by 21
Bayzigitov, D. R., Medvedev, S. P., Dementyeva, E. V., Афгановна, Б. С., Pokushalov, E. A., Karaskov, A. M., & Zakian, S. M. (2016) · Cardiology Research and Practice · doi:10.1155/2016/3582380 · Cited by 21
Atrial-specific hiPSC-derived cardiomyocytes in drug discovery and disease modeling
Gharanei, M., Shafaattalab, S., Sangha, S. S., Gunawan, M. G., Laksman, Z., Hove‐Madsen, L., & Tibbits, G. F. (2021) · Methods · doi:10.1016/j.ymeth.2021.06.009 · Cited by 21
Amniotic membrane as novel scaffold for human iPSC-derived cardiomyogenesis
Parveen, S., Singh, S. P., Panicker, M. M., & Gupta, P. K. (2019) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-019-00321-y · Cited by 21
Gélinas, R., Khoury, N. E., Chaix, M., Beauchamp, C., Alikashani, A., Éthier, N., Boucher, G., Villeneuve, L. R., Robb, L. J., Latour, F., et al. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.001755 · Cited by 21
Atmanli, A., & Domian, I. J. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.11.010 · Cited by 20
Schork, N. J., & Nazor, K. L. (2017) · Advances in genetics · doi:10.1016/bs.adgen.2017.06.001 · Cited by 20
In vitro clinical trials: the future of cell-based profiling
Ross, N. T., & Wilson, C. J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00121 · Cited by 20
Dolatshad, N. F., Hellen, N., Jabbour, R. J., Harding, S. E., & Földes, G. (2015) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2015.00076 · Cited by 20
Innovation in safety pharmacology testing
Pugsley, M. K., Towart, R., Authier, S., Gallacher, D. J., & Curtis, M. J. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2011.05.005 · Cited by 20
Martinez, Y., Dubois‐Dauphin, M., & Krause, K. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00047 · Cited by 20
Porta‐Sánchez, A., Mazzanti, A., Tarifa, C., Kukavica, D., Trancuccio, A., Mohsin, M., Zanfrini, E., Perota, A., Duchi, R., Hernández-López, K., et al. (2023) · Nature Cardiovascular Research · doi:10.1038/s44161-023-00393-w · Cited by 19
Suppression of ventricular arrhythmias by targeting late L-type Ca2+ current
Angelini, M., Pezhouman, A., Savalli, N., Chang, M. G., Steccanella, F., Scranton, K., Calmettes, G., Ottolia, M., Pantazis, A., Karagueuzian, H. S., et al. (2021) · The Journal of General Physiology · doi:10.1085/jgp.202012584 · Cited by 19
Kuusela, J., Larsson, K., Shah, D. A., Prajapati, C., & Aalto‐Setälä, K. (2017) · Biology Open · doi:10.1242/bio.024216 · Cited by 19
Cellular reprogramming: a novel tool for investigating autism spectrum disorders
Kim, K., Jung, Y. W., Sullivan, G. J., Chung, L., & Park, I. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.06.002 · Cited by 18
The genomic stability of induced pluripotent stem cells
Chen, Z., Zhao, T., & Xu, Y. (2012) · Protein & Cell · doi:10.1007/s13238-012-2922-8 · Cited by 18
Kalra, S., Montanaro, F., & Denning, C. N. (2016) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-150133 · Cited by 18
Modelling Human Channelopathies Using Induced Pluripotent Stem Cells: A Comprehensive Review
Müller, M., Seufferlein, T. T. W., Illing, A., & Homann, J. M. (2013) · Stem Cells International · doi:10.1155/2013/496501 · Cited by 18
Generation of Cardiomyocytes from Pluripotent Stem Cells
Nakahama, H., & Pasquale, E. D. (2014) · Methods in molecular biology · doi:10.1007/7651_2014_173 · Cited by 18
Tissue Contraction Force Microscopy for Optimization of Engineered Cardiac Tissue
Schaefer, J. A., & Tranquillo, R. T. (2015) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2015.0220 · Cited by 18
Fan, X., Yang, G., Duru, F., Grilli, M., Akın, İ., Zhou, X., Saguner, A. M., & El‐Battrawy, I. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10615-0 · Cited by 17
Kuusela, J., Kim, J., Räsänen, E., & Aalto‐Setälä, K. (2016) · Stem Cell Reviews and Reports · doi:10.1007/s12015-016-9686-0 · Cited by 17
Priori, S. G. (2011) · Circulation Research · doi:10.1161/circresaha.111.253724 · Cited by 17
Choreographing pluripotency and cell fate with transcription factors
Gonzales, K. A. U., & Ng, H. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.06.009 · Cited by 17
Nakao, S., Ihara, D., Hasegawa, K., & Kawamura, T. (2020) · European Cardiology Review · doi:10.15420/ecr.2019.03 · Cited by 17
Novak, A., Lorber, A., Itskovitz‐Eldor, J., & Binah, O. (2012) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10086 · Cited by 17
Transcriptomic analysis of pluripotent stem cells: insights into health and disease
Yeo, J.-C., & Ng, H. (2011) · Genome Medicine · doi:10.1186/gm284 · Cited by 17
Micheu, M. M., & Rosca, A. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i4.281 · Cited by 17
Verkerk, A. O., & Wilders, R. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1326160 · Cited by 17
Pasquale, E. D., Song, B., & Condorelli, G. (2013) · Journal of Visualized Experiments · doi:10.3791/50429 · Cited by 17
Penttinen, K., Siirtola, H., Àvalos-Salguero, J., Vainio, T., Juhola, M., & Aalto‐Setälä, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135806 · Cited by 16
Gu, X., Zhou, F., & Mu, J. (2021) · Medical Science Monitor · doi:10.12659/msm.931063 · Cited by 16
Current updates on arrhythmia within Timothy syndrome: genetics, mechanisms and therapeutics
Jiang, C., & Zhang, Y. (2023) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2023.11 · Cited by 16
Sigma non-opioid receptor 1 is a potential therapeutic target for long QT syndrome
Song, L., Bekdash, R., Morikawa, K., Quejada, J. R., Klein, A. D., Aina-Badejo, D., Yoshida, K., Yamamoto, H. E., Chalan, A., Yang, R., et al. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-021-00016-2 · Cited by 16
Self-citationVyas, V. S., & Lambiase, P. D. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00199 · Cited by 16
Loya, K. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386882-4.00011-6 · Cited by 16
Evolution of iPSC disease models
Zhang, W., Ding, Z., & Liu, G. (2012) · Protein & Cell · doi:10.1007/s13238-012-2005-x · Cited by 16
Induced Pluripotent Stem Cells: How They Will Change the Practice of Cardiovascular Medicine
Wong, W. T., Sayed, N., & Cooke, J. P. (2013) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcj-9-4-206 · Cited by 16
Tissue-Engineering for the Study of Cardiac Biomechanics
Ma, S. P., & Vunjak‐Novakovic, G. (2016) · Journal of Biomechanical Engineering · doi:10.1115/1.4032355 · Cited by 15
Many Cells Make Life Work—Multicellularity in Stem Cell-Based Cardiac Disease Modelling
Wang, B., Kit‐Anan, W., & Terracciano, C. M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113361 · Cited by 15
Lee, S., & Chung, S. (2016) · Stem Cells International · doi:10.1155/2016/2725670 · Cited by 15
Roscovitine Inhibits CaV3.1 (T-Type) Channels by Preferentially Affecting Closed-State Inactivation
Yarotskyy, V., & Elmslie, K. S. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187104 · Cited by 15
Ahmad, F. S., Jin, Y., Grassam-Rowe, A., Zhou, Y., Yuan, M., Fan, X., Zhou, R., Mu-u-min, R., O’Shea, C., Ibrahim, A. M., et al. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0312 · Cited by 15
Nguyen, H. X., Kirkton, R. D., & Bursac, N. (2018) · Nature Protocols · doi:10.1038/nprot.2018.016 · Cited by 14
Studying the pathophysiologic connection between cardiovascular and nervous systems using stem cells
Coskun, V., & Lombardo, D. M. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23924 · Cited by 14
Odedra, D., Chiu, L. L. Y., Reis, L. A., Rask, F., Chiang, K., & Radisic, M. (2010) · Springer eBooks · doi:10.1007/978-3-7091-0385-2_15 · Cited by 14
Eng, G. M., Lee, B. W., Radisic, M., & Vunjak‐Novakovic, G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398358-9.00038-0 · Cited by 14
Bamgboye, M. A., Traficante, M. K., Owoyemi, J. O., DiSilvestre, D. A., Vieira, D. C. O., & Dick, I. E. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.10.003 · Cited by 14
Induced Pluripotent Stem Cells and Induced Pluripotent Cancer Cells in Cancer Disease Modeling
Zhu, D., Kong, C. S. L., Gingold, J. A., Zhao, R., & Lee, D. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_257 · Cited by 14
Induced Pluripotent Stem Cell for the Study and Treatment of Sickle Cell Anemia
Reis, L. C. J., Picanço‐Castro, V., Paes, B. C. M. F., Pereira, O. A., Gyuricza, I. G., de Araújo, F. T., Morato-Marques, M., Moreira, L. F., Costa, E. D. B. O., dos Santos, T. P. M., et al. (2017) · Stem Cells International · doi:10.1155/2017/7492914 · Cited by 14
Metadata
- Authors
- Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., & Dolmetsch, R. E.
- Affiliations
- Stanford Medicine (US)
- Baylor College of Medicine (US)
- Corresponding author
- Dolmetsch, Ricardo E.
- ORCID
- Venue
- Nature
- Published
- 2011-02-09
- Volume
- 471
- Issue
- 7337
- Pages
- 230-234
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3077925
- OpenAlex
- W2026404421
- Cited by
- 677
- References
- 29
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 21 · 2023: 17 · 2022: 31 · 2021: 35 · 2020: 31 · 2019: 35 · 2018: 34 · 2017: 48 · 2016: 56 · 2015: 72 · 2014: 54 · 2013: 88 · 2012: 84
- FWCI
- 59.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Simons Foundation
- American Heart Association
- National Institutes of Health (DP1OD003889)
- Japan Society for the Promotion of Science
- National Institute of Mental Health (R21MH087898, DP1MH099904)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Keywords
- Timothy syndrome, induced pluripotent stem cells, cardiomyocytes, cardiac arrhythmias, CACNA1C, Cav1.2 L-type calcium channel, roscovitine, long QT syndrome, calcium signaling, electrophysiology, fibroblast reprogramming, drug screening
- MeSH terms
- Roscovitine, Action Potentials, Autistic Disorder, Drug Evaluation, Preclinical, Fibroblasts, Humans, Long QT Syndrome, Phenotype, Purines, Syndactyly, Patch-Clamp Techniques, Calcium Signaling, Mutation, Missense, Calcium Channels, L-Type, Myocytes, Cardiac, Cell Transdifferentiation, Induced Pluripotent Stem Cells, HEK293 Cells, Single-Cell Analysis, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.